Ångestsyndromens förekomst och möjliga konsekvenser av utebliven eller inadekvat behandling

References

• v Korff M., Shapiro S., Burke JD, et al. Anxiety and depression in a primary care clinic. Comparison of Diagnostic Interview Schedule General Health Questionnaire and Practitioner Assessments. Arch Gen Psychiatry 1987; 44: 152–6
   Google Scholar
• Catalan J., Gath D., Bond A., Martin P. The effects of non-prescribing of anxiolytics in general practice. Br J Psychiatry 1984; 144: 603–10
   PubMedGoogle Scholar
• Blacker CVR, Clare A. W. Depressive disorder in primary care. Br J Psychiatry 1987; 150: 737–51
   PubMed Web of Science ®Google Scholar
• Wilkinson G. Mental Health Practices in Primary-Care Settings. An Annotated Bibliography 1977–1985. Tavistock Publ., London 1985
   Google Scholar
• Wilkinson G., Smeton N., Skuse D., Fry J. Consultation for physical illnesses by patients diagnosed and treated for psychiatric disorders by a general practitioner: 20 year follow up study. Br Med J 1988; 297: 776–8
   PubMedGoogle Scholar
• Balestrieri M., Williams P., Wilkinson G. Specialist mental health treatment in general practice: a meta-analysis. Psychol Med 1988; 18: 711–7
   PubMed Web of Science ®Google Scholar
• Angst J., Dobler-Mikola A. The Zurich study. VI. A continuum from depression to anxiety disorders?. Eur Arch Psychiatr Neurol Sci 1985; 235: 179–86
   PubMedGoogle Scholar
• Eaton W. W., Ritter C. Distinguishing anxiety and depression with field survey data. Psychol Med 1988; 18: 155–66
   PubMed Web of Science ®Google Scholar
• Shephard M., Wilkinson G. Primary care as the middle ground for psychiatric epidemiology. Psychol Med 1988; 18: 263–7
   Google Scholar
• Barlow D. H., Blanchard E. B., Vermilyea JA, et al. Generalized anxiety and generalized anxiety disorder: Description and reconceptualization. Am J Psychiatry 1986; 143: 40–4
   PubMedGoogle Scholar
• Weissman M. M. Anxiety and alcoholism. J Clin Psychiatry 1988; 49((10, suppl))17–9
   Google Scholar
• Wells K. B., Golding J. M., Burnam M. A. Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiatry 1988; 145: 976–81
   PubMed Web of Science ®Google Scholar
• Kaplan H. S. Anxiety and sexual dysfunction. J Clin Psychiatry 1988; 49((10, suppl))21–25
   Google Scholar
• Murphy J. M., Olivier D. C., Sobol AM, et al. Diagnosis and outcome: depression and anxiety in a general population. Psychol Med 1986; 16: 117–26
   PubMedGoogle Scholar
• Murphy J. M., Olivier D. C., Monson RR, et al. Incidence of depression and anxiety: The Stirling County Study. Am J Public Health 1988; 78: 534–40
   PubMedGoogle Scholar
• Regier D. A., Boyd J. H., Burke JD, et al. One-month prevalence of mental disorders in the United States. Arch Gen Psychiatry 1988; 45: 977–86
   PubMed Web of Science ®Google Scholar
• Haines A. P., Imeson J. D., Meade T. W. Phobic anxiety and ischaemic heart disease. Br Med J 1987; 295: 297–9
   Google Scholar
• Coryell W., Noyes R., Clancy J. Excess mortality in panic disorder. A comparison with primary unipolar depression. Arch Gen Psychiatry 1982; 39: 701–3
   PubMed Web of Science ®Google Scholar
• Coryell W., Noyes R., House J. D. Mortality among outpatients with anxiety disorders. Am J Psychiatry 1986; 143: 508–10
   PubMed Web of Science ®Google Scholar
• Allgulander C. Psychoactive drug use in a general population sample. Correlates with perceived health psychiatric diagnoses and mortality in an automated record-linkage study. Am J Public Health 1989; 79: 1006–10
   PubMed Web of Science ®Google Scholar
• Piesiur-Strehlow B., Strehlow U., Poser W. Mortality of patients dependent on benzodiazepines. Acta Psychiatr Scand 1986; 73: 330–5
   PubMedGoogle Scholar
• Allgulander C., Ljungberg L., Fisher L. D. Long-term prognosis in addiction on sedative and hypnotic drugs analyzed with the Cox regression model. Acta Psychiatr Scand 1987; 75: 521–31
   PubMed Web of Science ®Google Scholar
• Kripke D. F., Simons R. N., Garfinkel L., Hammond C. Short and long sleep and sleeping pills. Is increased mortality associated?. Arch Gen Psychiatry 1979; 36: 103–16
   PubMed Web of Science ®Google Scholar
• Marks J. Chronic anxiolytic treatment: Benefit and risk. Adv Biochem Psychopharmacol 1985; 40: 173–83
   PubMedGoogle Scholar
• Socialstyrelsens Workshop. Pharmacological Treatment of Anxiety 1988; 1
   Google Scholar
• Tyrer P. Dependence as a limiting factor in the clinical use of minor tranquilizers. Pharmac Ther 1988; 36: 173–88
   PubMed Web of Science ®Google Scholar
• Uhlenhuth E. H., DeWit H., Baiter MB, et al. Risks and benefits of long-term benzodiazepine use. J Clin Psychopharmacol 1988; 8: 161–7
   PubMed Web of Science ®Google Scholar
• Rodrigo E. K., King M. B., Williams P. Health of long-term benzodiazepine users. Br Med J 1988; 296: 603–6
   PubMed Web of Science ®Google Scholar
• Mant A., Duncan-Jones P., Saltman D, et al. Development of long term use of psychotropic drugs by general practice patients. Br Med J 1988; 296: 251–4
   PubMed Web of Science ®Google Scholar
• Goldberg D., Huxley P. Mental Illness in the Community. Tavistock Publ., The Pathway to Psychiatric Care. London 1980
   Google Scholar
• Ware J. E., Manning W. G., Duan N, et al. Health status and the use of outpatient mental health services. Amer Psychologist 1984; 39: 1090–100
   PubMed Web of Science ®Google Scholar
• Mumford E., Schlesinger H. J., Glass GV, et al. A new look at evidence about reduced cost of medical utilization following mental health treatment. Am J Psychiatry 1984; 141: 1145–58
   PubMed Web of Science ®Google Scholar
• Smith G. R., Monson R. A., Ray D. C. Psychiatric consultation in somatization disorder. A randomized controlled study. N Engl J Med 1986; 314: 1407–13
   PubMed Web of Science ®Google Scholar
• Edlund M. J., Swann A. C. The economic and social costs of panic disorder. Hosp Comm Psychiatry 1987; 38: 1277–88
   PubMedGoogle Scholar
• Fulop G., Strain J. J., Vita J, et al. Impact of psychiatric comorbidity on length of hospital stay for medical/surgical patients: a preliminary report. Am J Psychiatry 1987; 144: 878–92
   PubMed Web of Science ®Google Scholar
• Guyatt G. H., Bombardier C., Tugwell P. X. Measuring disease-specific quality of life in clinical trials. Can Med Assoc J 1986; 123: 889–95
   Google Scholar
• Croog S. H., Levine S., Testa MA, et al. The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986; 314: 1657–64
   PubMed Web of Science ®Google Scholar
• Caplan R. D., Andrews F. M., Conway TL, et al. Social effects of diazepam use: A longitudinal field study. Soc Sci Med 1985; 21: 887–98
   PubMed Web of Science ®Google Scholar
• Lasagna L. The Halcion story: Trial by media. Lancet 1980; 1: 815–6
   PubMedGoogle Scholar
• Cohen S. Current attitudes about the benzodiazepines. Trial by Media. J Psychoactive Drugs 1983; 15: 109–13
   PubMed Web of Science ®Google Scholar
• Jick H. Early pregnancy and benzodiazepines. J Clin Psychopharmacol 1988; 8: 159–60
   Google Scholar
• Malmfors T., Slovi P., Kraus N, et al. Allmänhetens uppfattning av risker och läkemedelsbehandling. Sv FarmacTidskr 1988; 92: 31–7
   Google Scholar
• Clinthorne J. K., Cisin I. H., Baiter MB, et al. Changes in popular attitudes and beliefs about tranquilizers. Arch Gen Psychiatry 1986; 43: 527–32
   PubMed Web of Science ®Google Scholar